TrialBlood advances2020

Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: the HOVON-87/NMSG-18 trial.

Rowan Kuiper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.